The Venture Codex Logo

The Venture Codex

Overview

Develops self-regulating drugs for targeted therapeutic activity.

Total Raised

$30 M

Rounds

3

Links

Verticals

Biotechnology
Life Science
Pharmaceutical

Investment History

  1. Series B

    Dec 2021

    $8M

  2. Equity

    May 2020

    $11M

  3. Equity

    Feb 2019

    $11M

Team

Jacqueline Pham

Senior Associate Scientist

Shannon Fallen

Senior Associate Scientist

David Bienvenue

Senior Director, Protein Sciences

Jamie Nguyen

Associate Scientist II